Similar Items: CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
- Interchangeability of CSF and PET to identify Alzheimer's disease pathology
- Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literature
- Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
- Heritability of Alzheimer's disease–related plasma biomarkers in the Amish population
- APOE ε4 and Alzheimer's disease biomarkers in an American Indian community
- Short‐term psychological impacts of Alzheimer's disease risk disclosure based on blood‐biomarker results